1,942 reports of this reaction
4.5% of all ORLISTAT reports
#6 most reported adverse reaction
WEIGHT INCREASED is the #6 most commonly reported adverse reaction for ORLISTAT, manufactured by Haleon US Holdings LLC. There are 1,942 FDA adverse event reports linking ORLISTAT to WEIGHT INCREASED. This represents approximately 4.5% of all 43,367 adverse event reports for this drug.
Patients taking ORLISTAT who experience weight increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT INCREASED is moderately reported among ORLISTAT users, representing a notable but not dominant share of adverse events.
In addition to weight increased, the following adverse reactions have been reported for ORLISTAT:
The following drugs have also been linked to weight increased in FDA adverse event reports:
WEIGHT INCREASED has been reported as an adverse event in 1,942 FDA reports for ORLISTAT. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT INCREASED accounts for approximately 4.5% of all adverse event reports for ORLISTAT, making it a notable side effect.
If you experience weight increased while taking ORLISTAT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.